Literature DB >> 12702914

Does the use of insulin in a patient with liver dysfunction increase water retention in the body, i.e. cause insulin oedema?

Takahiro Zenda1, Yuko Murase, Isao Yoshida, Hiroaki Muramoto, Toshihide Okada, Kunimasa Yagi.   

Abstract

A 68-year-old female with mild diabetes mellitus was admitted because of acute liver dysfunction due to autoimmune hepatitis. While 40 mg/day of prednisolone improved hepatic dysfunction dramatically, her diabetic milieu deteriorated seriously. The induced hyperglycaemia could not be controlled sufficiently, despite a high dose of insulin (> 110 units/day), suggesting the existence of insulin insensitivity and hyperinsulinaemia. Soon after introduction of insulin therapy, she developed severe anasarca, including marked peripheral oedema, ascites and pleural effusion. Anasarca eventually subsided within 4 weeks with the use of a diuretic agent. We conjectured that the side effects of insulin, such as anti-natriuresis and increased vascular permeability, might be pronounced in the presence of the hepatic dysfunction that accompanies insulin insensitivity, hyperinsulinaemia and hypoalbuminaemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702914     DOI: 10.1097/01.meg.0000059107.41030.c7

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Insulin oedema in a child with newly diagnosed diabetes mellitus.

Authors:  Avinash Aravamudhan; Chris Gardner; Claire Smith; Senthil Senniappan
Journal:  Eur J Pediatr       Date:  2013-05-28       Impact factor: 3.183

2.  Inherited Real Risk of Type 2 Diabetes Mellitus: bedside diagnosis, pathophysiology and primary prevention.

Authors:  Sergio Stagnaro; Simone Caramel
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-26       Impact factor: 5.555

3.  Insulin-induced electrophysiology changes in human pleura are mediated via its receptor.

Authors:  V K Kouritas; M Ioannou; C N Foroulis; N Desimonas; K Evaggelopoulos; K I Gourgoulianis; P A Molyvdas; C Hatzoglou
Journal:  Exp Diabetes Res       Date:  2010-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.